- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Cystic fibrosis
- Meeting Date: July 2026
Elexacaftor with tezacaftor and with ivacaftor, and ivacaftor – July 2026
- Pack containing 28 sachets containing granules elexacaftor 100 mg with tezacaftor 50 mg and with ivacaftor 75 mg and 28 sachets containing granules ivacaftor 75 mg
Public Summary Documents
Last updated
13 November 2026
